Home - Products - Others - Other Targets - Apigenin 7-[rhamnosyl-(1->2)-galacturonide]

Apigenin 7-[rhamnosyl-(1->2)-galacturonide]

CAS No. 124167-97-1

Apigenin 7-[rhamnosyl-(1->2)-galacturonide]( —— )

Catalog No. M32292 CAS No. 124167-97-1

The leaves of Turpinia arguya Seem.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 551 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Apigenin 7-[rhamnosyl-(1->2)-galacturonide]
  • Note
    Research use only, not for human use.
  • Brief Description
    The leaves of Turpinia arguya Seem.
  • Description
    The leaves of Turpinia arguya Seem.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    124167-97-1
  • Formula Weight
    592.5
  • Molecular Formula
    C27H28O15
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • UDP-xylose disodium

    UDP-xylose disodium is a compound that can be isolated from Cryptococcus laurentii and is a sugar donor that can be used for the synthesis of glycoproteins, polysaccharides, various metabolites and oligosaccharides in plants, vertebrates and fungi.

  • BLU0588

    BLU0588 is a selective PRKACA inhibitor. BLU0588 inhibits PRKACA catalytic activity with a half-maximal inhibitory concentration (IC50) of 1 nM.

  • Amylin (8-37) (human...

    Amylin (8-37), human is a fragment of human Amylin. Amylin (8-37), human has direct vasodilator effects in the isolated mesenteric resistance artery of the rat. Human Amylin is a small hormone secreted by pancreatic β-cells that forms aggregates under insulin deficiency metabolic conditions, and it constitutes a pathological hallmark of type II diabetes mellitus.